These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6325316

  • 1. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N.
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [Abstract] [Full Text] [Related]

  • 2. Chromosome and cellular origin of choriocarcinoma.
    Wake N, Tanaka K, Chapman V, Matsui S, Sandberg AA.
    Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New concepts and questions in gestational trophoblastic disease.
    Dodson MG.
    J Reprod Med; 1983 Nov; 28(11):741-9. PubMed ID: 6361252
    [Abstract] [Full Text] [Related]

  • 7. The propensity to malignancy of dispermic heterozygous moles.
    Wake N, Fujino T, Hoshi S, Shinkai N, Sakai K, Kato H, Hashimoto M, Yasuda T, Yamada H, Ichinoe K.
    Placenta; 1987 Nov; 8(3):319-26. PubMed ID: 2821529
    [Abstract] [Full Text] [Related]

  • 8. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N, Arima T, Matsuda T.
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-S8. PubMed ID: 29645259
    [Abstract] [Full Text] [Related]

  • 9. [HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].
    Couillin P, Ravisé N, Afoutou JM, Chaïbi R, Azoulay M, Hors J, Oury JF, Boué J, Boué A.
    Ann Genet; 1987 Apr; 30(4):197-208. PubMed ID: 3501264
    [Abstract] [Full Text] [Related]

  • 10. [Identification of a chromosome carrying a putative tumor suppressor gene in human choriocarcinoma by microcell-mediated chromosome transfer].
    Miyamoto S, Sasaki M, Nishida M, Wake N.
    Hum Cell; 1991 Mar; 4(1):38-43. PubMed ID: 1888703
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relaxation of imprinting in trophoblastic disease.
    Ariel I, Lustig O, Oyer CE, Elkin M, Gonik B, Rachmilewitz J, Biran H, Goshen R, de Groot N, Hochberg A.
    Gynecol Oncol; 1994 May; 53(2):212-9. PubMed ID: 8188082
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic origin of a trophoblastic choriocarcinoma.
    Chaganti RS, Koduru PR, Chakraborty R, Jones WB.
    Cancer Res; 1990 Oct 01; 50(19):6330-3. PubMed ID: 1976039
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The propensity to malignant changes in heterozygous moles].
    Seki T, Fujita H, Okubo H, Shiina Y, Wake N, Ichinoe K, Kuroda M, Satoh H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec 01; 34(12):2221-8. PubMed ID: 7153599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.